Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) closed the day trading at $1.15 down -2.54% from the previous closing price of $1.18. In other words, the price has decreased by -$2.54 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
For a better understanding of RVPH, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.39 and its Current Ratio is at 0.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on September 20, 2023, initiated with a Buy rating and assigned the stock a target price of $12.
On June 08, 2023, The Benchmark Company started tracking the stock assigning a Speculative Buy rating and target price of $17.
On January 24, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.H.C. Wainwright initiated its Buy rating on January 24, 2022, with a $10 target price.
Stock Price History:
Over the past 52 weeks, RVPH has reached a high of $4.28, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -34.38%, while the 200-Day Moving Average is calculated to be -16.70%.
Shares Statistics:
A total of 46.58M shares are outstanding, with a floating share count of 41.63M. Insiders hold about 10.62% of the company’s shares, while institutions hold 22.12% stake in the company.
